Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
β-alanine as an Adjunct to First-line Immunotherapy in Advanced Hepatocellular Carcinoma
NCT07317414Phase 2Recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Dec 2025
- Primary completion
- Dec 2028
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of beta-alanine in hepatocellular carcinoma (HCC), sponsored by Peking Union Medical College Hospital. Started Dec 2025; status: recruiting.
02
Drugs
beta-alanine
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT07317414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07317414.